Newlands Management Operations’s Moderna MRNA Stock Holding History

Newlands Management Operations’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$424K	Hold	6,053	–	–	﹤0.01%	16
2026 Q1	$307K	Buy	+6,053	New	+$282K	﹤0.01%	16
2025 Q1	–	Sell	-6,053	Closed	-$252K	–	25
2024 Q4	$252K	Hold	6,053	–	–	﹤0.01%	25
2024 Q3	$405K	Hold	6,053	–	–	﹤0.01%	21
2024 Q2	$719K	Hold	6,053	–	–	0.01%	20
2024 Q1	$645K	Hold	6,053	–	–	0.01%	28
2023 Q4	$602K	Hold	6,053	–	–	0.01%	28
2023 Q3	$625K	Hold	6,053	–	–	0.01%	28
2023 Q2	$735K	Hold	6,053	–	–	0.01%	27
2023 Q1	$930K	Hold	6,053	–	–	0.02%	22
2022 Q4	$1.09M	Buy	+6,053	New	+$990K	0.03%	22

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Newlands Management Operations's MRNA Position: Q2 2026 in Review

Newlands Management Operations held its Moderna (MRNA) position steady in Q2 2026 at 6,053 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #16.

Newlands Management Operations first reported a position in MRNA in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.09M in Q4 2022. 781 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Newlands Management Operations held 6,053 shares of Moderna worth $424K as of Q2 2026.
Newlands Management Operations left its Moderna share count unchanged in Q2 2026.
Moderna made up ﹤0.01% of Newlands Management Operations's portfolio in Q2 2026, its #16 holding.
Newlands Management Operations first reported a position in Moderna in Q4 2022 and has held it in 11 quarters since.
Newlands Management Operations's Moderna position peaked at $1.09M in Q4 2022.
781 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Newlands Management Operations's 13F filing for Q2 2026, filed 14 Aug 2026.